Stifel Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $80
Globus Medical (GMED) Receives a Buy From Stifel Nicolaus
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $78
Globus Medical Is Maintained at Outperform by RBC Capital
Globus Medical Analyst Ratings
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $80
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $77
Globus Medical (GMED) Receives a Buy From BTIG
Globus Medical Is Maintained at Buy by BTIG
Globus Medical Analyst Ratings
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $77
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $78
Buy Rating Affirmed for Globus Medical Despite FDA Warning: Manageable Regulatory Challenges Ahead
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED), Avidity Biosciences (RNA) and Veeva Systems (VEEV)
Barclays Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $93
Truist Financial Maintains Globus Medical(GMED.US) With Hold Rating
Oppenheimer Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $73
Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $85
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $55 to $93
Truist Financial Gives a Hold Rating to Globus Medical (GMED)